ABBOTT LABORATORIES — Director's Dealing 2004

Feb 24, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-02-20

Reporting Person: WHITE MILES D (Director, Chairman, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-02-20	Common shares without par value	A	55000	$43.66	Acquired	551685	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-02-20	Option (right to buy)	$43.66	A	380000	Acquired	2014-02-19	common shares (380000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	13999	Indirect
Common shares without par value	3193	Indirect
Common shares without par value	3193	Indirect
Common shares without par value	3193	Indirect

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 20, 2004.

F3: The reporting persons disclaims beneficial ownership of all securities held by his sons.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 126,667 on 2/20/05, 126,666 on 2/20/06 and 126,667 on 2/20/07